Bond And Money Market

We present a matrix detailing some movement in some key market rates (domestic and global) and key events:

Parameters 26-Feb-21 29-Jan-21 28-Feb-20
RBI Repo Rate % 4.00 4.00 5.15
5Y AAA PSU % 6.10 5.65 6.95
1 year CD % 4.25 3.97 6.17
10Y Gsec % 5.91 5.88 6.47
CPI (%) 4.06 4.59 7.59
IIP (FYTD) % 1.00 -2.10 2.20
US 10Y % 1.40 1.06 1.15
Dollar Rupee 73.46 72.95 72.17

Source: Bloomberg; Data as on February 26th, 2021

The month witnessed one of the sharpest rise in the rates in the last one year. The benchmark 10-year yield rose by around 25 basis points (bps) through the month while the 2-5 year corporate bonds witnessed a sharp upward movement of around 50 bps. The money market rates on the 1-year segment too sold off, and the only space offering some respite for the debt markets was the extreme short-term rates offering some respite due to the surplus liquidity in the banking system.

The monetary policy committee meeting held in February had reiterated its stance of a continued accommodative stance and the RBI Governor too spoke of a supportive central bank in keeping rates low. However, a large Central and State Government borrowing program, elevated commodity prices, a rising crude and a possible banking credit growth in the future was reflected in a sell-off in the debt markets despite RBI assurances.

Looking Ahead
  • We remain apprehensive of a gradual rate rise as we move through the next year. We believe that the markets may have stopped coat tailing the RBI, and are not ignoring a commodity prices rise-induced inflation and a larger borrowing program
  • The possibility of a bear flattening of the yield curve exists with long term rates rising lesser than short term rates
  • Liquidity being in sustained surplus mode, the extreme short end of the yield curve may remain stable.
Scheme Specific Strategies for Debt schemes
  • Mahindra Manulife Low Duration Fund
  • Mahindra Manulife Ultra Short Term Fund
    • The average maturity of the portfolio is around 133 days
    • We would maintain a similar maturity as we move ahead
    • The YTM of the portfolio is around 3.84 %
    • With surplus liquidity conditions, we expect the extreme short end money market rates to remain benign
  • Mahindra Manulife Liquid Fund
    • We continue to maintain a healthy mix of certificate of deposits and commercial papers
    • We will attempt to ensure adequate liquidity, safety and accrual
  • Mahindra Manulife Credit Risk Fund
    • We intend to hold the cash in the portfolio for some time in the future and re-deploy the same as uncertainties recedes and investor confidence returns in debt markets
    • The YTM of the portfolio has decreased to around 4.96%.
    • The Modified Duration of the portfolio is around 1.34 years
  • Mahindra Manulife Short Term Fund
    • We are in the process of the portfolio construction as per the mandate of the scheme
    • We intend to be at the lower end of the permissible Macaulay Duration range as we create the portfolio
Equity Market outlook and overview

We present a summary of changes in key Indian & Global equity indices

S&P BSE Sensex Nifty 50 BSE Midcap BSE Small Cap Nifty Midcap 100 Nifty Small Cap 100 Dow Jones Indus. Avg S&P 500 Index Nasdaq Composite Index
1 Mth Performance 6.1% 6.6% 10.5% 12.0% 11.3% 12.2% 3.2% 2.6% 0.9%
1 Yr Performance 57.4% 37.7% 36.8% 47.0% 38.6% 41.8% 21.7% 29.0% 54.0%

Source: Bloomberg Performance - Absolute returns | Data as on 26 Feb, 2021

Equity Market Update

Globally, equity markets continue to remain bullish with expectations of economic recovery post the Covid vaccination driving the sentiments. The liquidity comfort remains strong as evident from multiple comments by policy makers in US on both monetary policy, as well as fiscal policy front. With the new US President coming in, we could see changes on quite a few fronts. While any change in stimulus and fiscal policy will definitely impact economy, any change in foreign policies may also influence the global economics and asset prices.

Indian markets again had a good month with a sharp recovery across indices to make a new high. The pre-budget fall in markets that we saw in January was fully recovered post the Union Budget announcement. Mid and Small cap indices fared significantly better than Nifty as focus continues to shift on broader markets. This is quite similar to trends being seen across the global markets where the recovery is broad-based. Among large sectors in market; Financials, Commodities, Energy outperformed Nifty while IT, FMCG, Pharma underperformed Nifty. The rotation among sectoral indices continue in Indian markets as leaders change almost every month. From FII flow perspective, Indian equity markets continue to attract strong flows in-line with quite a few emerging markets.

The economic normalization continues with improving data across economic indicators. GDP for Q3FY21 came in at 0.4% and this set the tone for some upgrades in GDP outlook for FY21. The consensus shifted towards a significant growth in FY22 with estimates ranging from 8% to 13%. These estimates put India as among the fastest growing economies in FY22.

Union budget for FY22 was presented during the month with a focus laid down on economic growth. Finance minister relaxed the fiscal deficit constraints under Fiscal Responsibility and Budget Management (FRBM) to prefer growth in next 2-3 years. We believe that focus on growth is what India needs from the government, especially when private sector is busy exploring growth opportunities presented under “production linked incentive (PLI) schemes” or “China Plus One” sourcing plans of global corporates.

The corporate results for Q3FY21 have been quite strong vis-a-vis the expectations. The corporate profits have been quite strong as they gained market shares over unorganized competitors, and also gained from strong cost-cutting. Indian corporates are likely to report a good profit growth in FY21 vis-a-vis the estimates at beginning of the year. Moreover, the profit growth is significant in light of around 8% decline in GDP expected for FY21. The profitability has grown, despite a fall in volumes, essentially on account of cost reductions across the operations.

Looking Ahead

The economies continue to be in lockdown in several countries. The real scare on growth was in March, 2020, but strong and coordinated monetary and fiscal support by policymakers across the globe have helped prevent an economic accident. As we move ahead, next 4-6 months may show good data points on YoY basis as the base was quite low. The real challenge is how much of inflation scare could revert in US as inflation could lead to bond yields in US rising and impacting all asset classes. We would continue to monitor data points as well as Fed commentary on the outlook for inflation and monetary policy stance in US.

As the economic recovery is getting traction across the globe, metal prices as well as crude oil prices have rallied sharply. This may hit cost structures and going ahead it would be a delicate balance between maintaining margins and growing volumes for many corporates. While the expected growth in earnings look good for FY22 based on the expected economic growth, we would monitor the growth vs profitability equation as we look for more data points on the same.

The markets have proven in last 12 months that it has its own volatile phases where investors’ psyche oscillate between fear and greed. While it may be a bit difficult for investors to avoid these phases, it is definitely possible for investors to avoid acting in haste during those phases. A strategy to keep a focus on longer term of 3-5-7 years definitely helps in avoiding hasty decisions in fearful times. Thus, SIP could be a good alternate to avoid the behavioural traps during the extreme phases of markets. We maintain that investors could use SIP as part of their core investment philosophy and use the lumpsum route during the extreme fearful phases to top-up on their SIPs.

Scheme Specific Strategies for Equity schemes
  • Mahindra Manulife Multi Cap Badhat Yojana
  • Mahindra Manulife Mid Cap Unnati Yojana
  • Mahindra Manulife ELSS Kar Bachat Yojana
  • Mahindra Manulife Rural Bharat and Consumption Yojana
  • Mahindra Manulife Large Cap Pragati Yojana
  • Mahindra Manulife Top 250 Nivesh Yojana
  • Mahindra Manulife Focused Equity Yojana
Scheme Specific Strategies For Hybrid Schemes
  • Mahindra Manulife Equity Savings Dhan Sanchay Yojana
  • Mahindra Manulife Hybrid Equity Nivesh Yojana

    Equity:

    • Portfolio composition would have preference for growth style of investing.
    • Bottom-up approach would be adopted to identify companies that have ability to scale up, gain market share and/or are present in sunrise/high growth sectors.

    Debt:

    • The Modified duration of the portfolio is around 3.77 years of the debt portion
    • The current asset allocation has an equal allocation to AAA credits and GoI securities
What should an investor do?

For investments in debt oriented products:

  • We believe that the investors with a shorter investment horizon may continue investments in ultra-short term and low duration funds
  • For a long investment horizon and with a suitable risk appetite, an allocation to short term fund merits attention

For investments in equity oriented products:

  • Our view is that volatility may continue and SIP may be a good way to increase equity market allocations
  • We believe investors with shorter investment horizon and lower risk appetite, may invest in arbitrage fund to hedge against volatility
  • Investors looking to invest for a longer period, can consider SIPs or STPs into focused, multicap or balanced funds based on risk appetite.
  • Investors looking for a better return opportunity and with a suitable risk appetite, may consider part allocation in the mid cap scheme as well.

Scheme Name Product Suitability Riskometer
Mahindra Manulife Overnight Fund
An open ended debt scheme investing in overnight securities
This Product is suitable for investors who are seeking*:
  • To generate reasonable returns with high levels of safety and convenience of liquidity over short term
  • To invest in debt and money market instruments having maturity of upto 1 business day
Mahindra Manulife Arbitrage Yojana
An open ended scheme investing in arbitrage opportunities
This Product is suitable for investors who are seeking*:
  • Income over short term
  • Income through arbitrage opportunities between cash and derivative market and arbitrage opportunities within the derivative segment.
Mahindra Manulife Liquid Fund
An Open Ended Liquid scheme
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in money market and debt instruments
Mahindra Manulife Short Term Fund
An open ended short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 1 year and 3 years (please refer to page no. 35 of SID)
This Product is suitable for investors who are seeking*:
  • Income over short to medium term.
  • Investment in debt and money market instruments.
Mahindra Manulife Low Duration Fund
An open ended low duration debt scheme investing in instruments such that the Macaulay duration of the Portfolio is between 6 months and 12 months (Please refer page 31 of SID)
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in debt and money market instruments
Mahindra Manulife Ultra Short Term Fund
An open ended ultra-short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 3 to 6 months (please refer to page no. 31 of SID)
This Product is suitable for investors who are seeking*:
  • Regular Income over short term.
  • Investment in a portfolio of short term debt and money market instruments.
Mahindra Manulife Credit Risk Fund
An open ended debt scheme predominantly investing in AA and below rated corporate bonds (excluding AA+ rated corporate bonds)
This Product is suitable for investors who are seeking*:
  • To generate regular returns and capital appreciation over medium term.
  • Investment predominantly in AA and below rated corporate bonds, debt, government securities and money market instruments while maintaining the optimum balance of yield, safety and liquidity.
Mahindra Manulife Equity Savings Dhan Sanchay Yojana
An open ended scheme investing in equity, arbitrage and debt
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income
  • Investment in equity and equity related instruments, arbitrage opportunities and debt and money market instruments
Mahindra Manulife ELSS Kar Bachat Yojana
An open ended equity linked saving scheme with a statutory lock in of 3 years and tax benefit
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities
Mahindra Manulife Focused Equity Yojana
An open ended equity scheme investing in maximum 30 stocks across market caps (i.e Multi Cap)
This Product is Suitable for investors who are seeking*
  • Long term capital appreciation
  • Investment in equity and equity related instruments in concentrated profile of maxium 30 stocks across market capitalziation.
Mahindra Manulife Top 250 Nivesh Yojana
Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term wealth creation and income
  • Investment predominantly in equity and equity related securities of large and Mid cap companies.
Mahindra Manulife Multi Cap Badhat Yojana
Multi Cap Fund- An open ended equity scheme investing across large cap, mid cap, small cap stocks
This Product is suitable for investors who are seeking*:
  • Medium to Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives.
Mahindra Manulife Mid Cap Unnati Yojana
Mid Cap Fund – An open ended equity scheme predominantly investing in mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of mid cap companies
Mahindra Manulife Large Cap Pragati Yojana
Large Cap Fund - An open ended equity scheme predominantly investing in large cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of large cap companies.
Mahindra Manulife Hybrid Equity Nivesh Yojana
An open ended hybrid scheme investing predominantly in equity and equity related instruments
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income;
  • Investment in equity and equity related instruments and debt and money market instruments
Mahindra Manulife Rural Bharat and Consumption Yojana
An open ended scheme following Rural India theme
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of entities engaged in and/ or expected to benefit from the growth in rural India.

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them

The views expressed here in this material are for general information and reading purpose only and do not constitute any guidelines and recommendations on any course of action to be followed by the reader. No representation or warranty is made as to the accuracy, completeness or fairness of the information and opinions contained herein. The views are not meant to serve as a professional guide / investment advice / intended to be an offer or solicitation for the purchase or sale of any financial product or instrument or mutual fund units for the reader. This material has been prepared on the basis of publicly available information, internally developed data and other sources believed to be reliable. While utmost care has been exercised while preparing this material, Mahindra Manulife Investment Management Private Limited (formerly known as Mahindra Asset Management Company Private Limited) (AMC) does not warrant the completeness or accuracy of the information and disclaims all liabilities, losses and damages arising out of the use of this information. The data/statistics given in this material are to explain general market trends in the securities market, it should not be construed as any research report/research recommendation. Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Mutual Fund, the AMC nor Mahindra Manulife Trustee Private Limited (formerly known as Mahindra Trustee Company Private Limited), its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

Cno. 00933

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.